Carlsmed, Inc. Common Stock (CARL) is a publicly traded Healthcare sector company. As of October 27, 2026, CARL trades at $15.42 with a market cap of $407.08M and a P/E ratio of -7.13. CARL moved +3.62% today. Year to date, CARL is +32.59%; over the trailing twelve months it is +13.88%. Its 52-week range spans $8.50 to $17.23. Analyst consensus is strong buy with an average price target of $19.67. Rallies surfaces CARL's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Carlsmed names Richard Heppenstall CFO, replacing Leo Greenstein: Carlsmed named Richard Heppenstall chief financial officer, effective immediately, replacing Leo Greenstein, who is leaving to pursue other interests. The company reaffirmed full-year 2026 revenue guidance of $74 million to $78 million.
| Metric | Value |
|---|---|
| Price | $15.42 |
| Market Cap | $407.08M |
| P/E Ratio | -7.13 |
| EPS | $-2.12 |
| Dividend Yield | 0.00% |
| 52-Week High | $17.23 |
| 52-Week Low | $8.50 |
| Volume | 83.73K |
| Avg Volume | 0 |
| Revenue (TTM) | $50.51M |
| Net Income | $-29.63M |
| Gross Margin | 75.31% |
5 analysts cover CARL: 0 strong buy, 5 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $19.67.